Navigation Links
Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
Date:11/5/2008

SAN DIEGO, Nov. 5 /PRNewswire/ -- Ambrx Inc. today announced the scheduled presentation of data from a Phase I/II clinical trial of ARX201, the company's long-acting human growth hormone (hGH) analogue developed in collaboration with Merck Serono, at the International Congress of Endocrinology meeting in Rio de Janeiro. Andrew R. Hoffman, M.D., Professor of Medicine and Vice President of Academic Affairs at Stanford University, will present the clinical results as part of an oral presentation at 9:30 AM local time (GMT -3 / 7:30 AM EST) on November 12, 2008.

The Phase I/II dose-finding study in adult patients with growth hormone deficiency investigated the safety, tolerability, pharmacokinetic and pharmacodynamic profile of ARX201 following single-dose escalation and repeated dosing. The study analyzed 22 individuals with adult growth hormone deficiency (AGHD). The patients had not received hGH replacement therapy in the six months prior to the study.

ARX201 was administered once weekly by subcutaneous injection. Dosing was titrated based on IGF-I response and/or safety findings. Patients were treated for up to 26 weeks. Clinical measures of body composition were taken at the end of the study period.

About ARX201

ARX201 is a long-acting recombinant human growth hormone drug candidate currently developed by Ambrx and Merck Serono for the treatment of growth hormone deficiencies. ARX201 was generated through a lead optimization process using Ambrx's ReCODE(TM) technology, which effectively enables protein medicinal chemistry. Through this approach, Ambrx was able to generate site specific mono-pegylated hGH molecules that were optimized for potency and time of action. Ambrx believes that ARX201 may have improved pharmacological performance over existing growth hormone products, including the potential for less frequent dosing.

In pre-clinical studies, ARX201 met or exceeded key end points in assays that are believed to be pred
'/>"/>

SOURCE Ambrx Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
2. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
3. Avicena Group to Present at Noble Financial Conference
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CEL-SCI to Present at the Noble Financial Conference
8. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Strategic Diagnostics Updates Roth Conference Presentation Time
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2013)... 06, 2013 In their latest ... Contract Manufacturing of Injectable Drugs Through 2019,” ... latest trends and plans for outsourcing commercially approved ... comprehensive database of the dose CMO industry - ... Service Providers - the analytical model and assumptions ...
(Date:12/5/2013)... Standards and Technology (NIST) and Sandia National ... family of engineered, high-tech materials called metal-organic ... This breakthroughconductive MOFshas the potential to make ... particularly for detecting gases and toxic substances. ... nanoscale pores made up of metal ions ...
(Date:12/5/2013)... hold promise for understanding and treating neurodegenerative diseases, but ... that occur late in life. A study published by ... Stem Cell has revealed a new method for ... that recapitulate features associated with aging as well as ... cells to a protein associated with premature aging called ...
(Date:12/5/2013)... semiconductor structures called nanowires, so thin that ... lasers for applications in computing, communications, and ... (TUM) have demonstrated laser action in semiconductor ... wavelengths and operate at room temperature. They ... journal Nature Communications and, in ...
Breaking Biology Technology:New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019 2Welcome guests: Added molecules allow metal-organic frameworks to conduct electricity 2Scientists accelerate aging in stem cells to study age-related diseases like Parkinson's 2Laser light at useful wavelengths from semiconductor nanowires 2Laser light at useful wavelengths from semiconductor nanowires 3
... be Only Once-Yearly Implant for Prostate Cancer in ... Indevus Reaffirms Commitment to Prostate Cancer Patients, ... (Nasdaq: IDEV ) today commented on the ... their product,Viadur(R) (leuprolide acetate implant), which is indicated ...
... Ill., Dec. 20 Baxter International,(NYSE: BAX ), ... 2007 financial results on Thursday, January 24, 2008, at ... the call, please dial,866-793-1307 (domestic) or 703-639-1309 (international). Please ... the start of the call for the,operator to connect ...
... Raven ... biotechnologies, SOUTH SAN FRANCISCO, ... announced today that,it has, along with Punk Ziegel and Company, begun ... the OTC Bulletin Board, and is,expected to commence trading by the ...
Cached Biology Technology:Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R) 2Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R) 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 4
(Date:12/6/2013)... of Medical Biology (IMB) and Institute of Molecular and ... hormone that could potentially be used as a therapeutic ... they have chosen to name ELABELA - is only ... made by the human body. , 2. The team ... determine ELABELA,s function, since its existence was hitherto unsuspected. ...
(Date:12/6/2013)... Institute for Collaborative Biotechnologies (ICB) has received an ... Research Laboratory-Army Research Office, providing an additional $48 ... is inspired by biological systems. The continuation in ... decade of fundamental research in the areas of ... neuroscience and medicine. , "This award extends the ...
(Date:12/5/2013)... For discoveries about how the brain calculates and remembers ... of memoryColumbia University will award the 2013 Louisa Gross ... Moser, PhD, of the Norwegian University of Science and ... University College London in the UK. Their work, conducted ... Alzheimer,s and other neurological disorders that affect the brain,s ...
Breaking Biology News(10 mins):A*STAR scientists discover novel hormone essential for heart development 2Army renews bio-inspired engineering and science research center at UC Santa Barbara with $48 million 2Army renews bio-inspired engineering and science research center at UC Santa Barbara with $48 million 3Columbia's 2013 Horwitz Prize awarded for discoveries that could lead to new Alzheimer's treatments 2Columbia's 2013 Horwitz Prize awarded for discoveries that could lead to new Alzheimer's treatments 3Columbia's 2013 Horwitz Prize awarded for discoveries that could lead to new Alzheimer's treatments 4Columbia's 2013 Horwitz Prize awarded for discoveries that could lead to new Alzheimer's treatments 5
... amount of time in an urban setting, the scene of a ... be all too familiar. But just how is it determined that ... or a lethal weapon? The most common way is spectroscopy. ... Eric Houser, a program manager in the Explosives Division of the ...
... As published today in Science , researchers from ... of plasticity in how transcription factors, the proteins that ... maintain their function over large evolutionary distances. The ... genes that they regulate by binding to short, sequence-specific ...
... Europe,s first mission dedicated to studying the Earth,s ice was ... send back data leading to new insights into how ice ... in our ,Earth system,. The CryoSat-2 satellite was launched ... by the International Space Company Kosmotras from the Baikonur Cosmodrome ...
Cached Biology News:Bomb scares: An ODD solution 2Bomb scares: An ODD solution 3Rewiring of gene regulation across 300 million years of evolution 2Successful launch for ESA's CryoSat-2 ice satellite 2
... ICS-1500 system provides excellent performance with ... electrolytic suppression, and column heater all ... outstanding sensitivity and stability. The vacuum ... for trace-level work. Operate in manual ...
... Odyssey images are easily imported for data analysis , ... ... results , Extensive background and signal options to ... results , ...
... UNIchip AV-400 contains 400 unique human ... glass slide. The proteins, a cross ... arrayed in quadruplicate for high-quality results. ... chip layout guarantee high validity and ...
...
Biology Products: